BioSpace News Archive

Perrigo will acquire full ownership of the ANDA under a pre-existing arrangement with its partner within 30 days and anticipates launching this product immediately thereafter.

The combined Caretaker & ETCO2 solution allows clinicians to monitor critical elements of patients’ respiratory status not previously possible in a wireless handheld device with remote data display and reporting.

On July 2, 2019, Chinese Red Cross Foundation initiated the “Rare Disease Care Movement” in Yinchuan City, Ningxia Hui Autonomous Region, China.

The latest SaaS-based case management software releases a new module to support time-tracking, billing and invoicing

Bioscience Association Manitoba (BAM) is proud to announce the release of the Bioscience Association Manitoba 2019 Industry Profile Study – the comprehensive analysis of the contributions our province’s bioscience companies are making to the local economy.

Focusing on what’s best for the patient, leveraging technology to perform real-time benefit checks, and developing trust and transparency among stakeholders are some of the suggestions to emerge from AMCP’s recent Partnership Forum on “Optimizing Prior Authorization for Appropriate Medication Selection.”

New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd.

LabShares Newton, a shared office and laboratory incubator for emerging biotechnology and life science companies, announced at Thursday’s MALSI Day that L Stem Therapeutics is the winner of the second Launch@LabShares competition, providing a $50K year-long membership, including scientific and operational support, to this novel diagnostics startup

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients

AgaMatrix, Inc. (“AgaMatrix”) and WaveForm Technologies, Inc. (“WaveForm”), wholly owned subsidiaries of AgaMatrix Holdings LLC, today announced that it closed on a total capital raise of $56 million.